The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial toxicity of hematologic malignancy therapies: Subjective experience of patients and impact on access to care.
 
Kateryna Fedorov
No Relationships to Disclose
 
Lemchukwu Amaeshi
No Relationships to Disclose
 
Rosmi Mathew
No Relationships to Disclose
 
David Levitz
No Relationships to Disclose
 
Daniel Cole
No Relationships to Disclose
 
Alex Sisto
No Relationships to Disclose
 
Kuldip Singh
No Relationships to Disclose
 
Kareh Fehn
No Relationships to Disclose
 
Mimi Kim
No Relationships to Disclose
 
Jianyou Liu
No Relationships to Disclose
 
Karen Wright
No Relationships to Disclose
 
Mendel Goldfinger
No Relationships to Disclose
 
Ioannis Mantzaris
No Relationships to Disclose
 
Alejandro R. Sica
No Relationships to Disclose
 
Dennis Cooper
No Relationships to Disclose
 
Marina Konopleva
Honoraria - Abbvie; Amgen; Amgen; Forty Seven; Genentech; KisoJi Biotechnology; Roche; Stemline Therapeutics
Consulting or Advisory Role - AbbVie; Amgen; Forty Seven; Genentech/Roche; Janssen; KisoJi Biotechnology; KisoJi Biotechnology; Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Agios (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Forty Seven (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Eli LIlly- Research Funding; Issued/ Licensed; Novartis- PENDING; Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities); Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities)
 
Amit Verma
No Relationships to Disclose
 
Bruce Rapkin
No Relationships to Disclose
 
Aditi Shastri
Honoraria - National Association of Continuing Education (NACE)
Consulting or Advisory Role - Gilead Sciences; Janssen; Kymera; Rigel
Research Funding - Kymera
 
Nishi Shah
No Relationships to Disclose